220 related articles for article (PubMed ID: 16496935)
1. Canine mast cell tumors: correlation of apoptosis and proliferation markers with prognosis.
Scase TJ; Edwards D; Miller J; Henley W; Smith K; Blunden A; Murphy S
J Vet Intern Med; 2006; 20(1):151-8. PubMed ID: 16496935
[TBL] [Abstract][Full Text] [Related]
2. Association of argyrophilic nucleolar organizing regions, Ki-67, and proliferating cell nuclear antigen scores with histologic grade and survival in dogs with soft tissue sarcomas: 60 cases (1996-2002).
Ettinger SN; Scase TJ; Oberthaler KT; Craft DM; McKnight JA; Leibman NF; Charney SC; Bergman PJ
J Am Vet Med Assoc; 2006 Apr; 228(7):1053-62. PubMed ID: 16579784
[TBL] [Abstract][Full Text] [Related]
3. Expression of Ki67, BCL-2, and COX-2 in canine cutaneous mast cell tumors: association with grading and prognosis.
Vascellari M; Giantin M; Capello K; Carminato A; Morello EM; Vercelli A; Granato A; Buracco P; Dacasto M; Mutinelli F
Vet Pathol; 2013 Jan; 50(1):110-21. PubMed ID: 22673539
[TBL] [Abstract][Full Text] [Related]
4. Cellular proliferation in canine cutaneous mast cell tumors: associations with c-KIT and its role in prognostication.
Webster JD; Yuzbasiyan-Gurkan V; Miller RA; Kaneene JB; Kiupel M
Vet Pathol; 2007 May; 44(3):298-308. PubMed ID: 17491070
[TBL] [Abstract][Full Text] [Related]
5. Recurrence rate, clinical outcome, and cellular proliferation indices as prognostic indicators after incomplete surgical excision of cutaneous grade II mast cell tumors: 28 dogs (1994-2002).
Séguin B; Besancon MF; McCallan JL; Dewe LL; Tenwolde MC; Wong EK; Kent MS
J Vet Intern Med; 2006; 20(4):933-40. PubMed ID: 16955819
[TBL] [Abstract][Full Text] [Related]
6. Cytologic Criteria for Mast Cell Tumor Grading in Dogs With Evaluation of Clinical Outcome.
Camus MS; Priest HL; Koehler JW; Driskell EA; Rakich PM; Ilha MR; Krimer PM
Vet Pathol; 2016 Nov; 53(6):1117-1123. PubMed ID: 27034386
[TBL] [Abstract][Full Text] [Related]
7. The use of KIT and tryptase expression patterns as prognostic tools for canine cutaneous mast cell tumors.
Kiupel M; Webster JD; Kaneene JB; Miller R; Yuzbasiyan-Gurkan V
Vet Pathol; 2004 Jul; 41(4):371-7. PubMed ID: 15232137
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical detection of proliferating cell nuclear antigen and Ki-67 in mast cell tumors from dogs.
Abadie JJ; Amardeilh MA; Delverdier ME
J Am Vet Med Assoc; 1999 Dec; 215(11):1629-34. PubMed ID: 14567425
[TBL] [Abstract][Full Text] [Related]
9. Prognostic Indicators and Clinical Outcome in Dogs with Subcutaneous Mast Cell Tumors Treated with Surgery Alone: 43 Cases.
Gill V; Leibman N; Monette S; Craft DM; Bergman PJ
J Am Anim Hosp Assoc; 2020; 56(4):215-225. PubMed ID: 32412337
[No Abstract] [Full Text] [Related]
10. Prognosis of canine mast cell tumors: a comparison of three methods.
Simoes JP; Schoning P; Butine M
Vet Pathol; 1994 Nov; 31(6):637-47. PubMed ID: 7863578
[TBL] [Abstract][Full Text] [Related]
11. Variation among pathologists in histologic grading of canine cutaneous mast cell tumors.
Northrup NC; Harmon BG; Gieger TL; Brown CA; Carmichael KP; Garcia A; Latimer KS; Munday JS; Rakich PM; Richey LJ; Stedman NL; Cheng AL; Howerth EW
J Vet Diagn Invest; 2005 May; 17(3):245-8. PubMed ID: 15945380
[TBL] [Abstract][Full Text] [Related]
12. Histologic grading of canine mast cell tumor: is 2 better than 3?
Sabattini S; Scarpa F; Berlato D; Bettini G
Vet Pathol; 2015 Jan; 52(1):70-3. PubMed ID: 24513799
[TBL] [Abstract][Full Text] [Related]
13. Expression of Fibroblast Activating Protein and Correlation with Histological Grade, Mitotic Index and Ki67 Expression in Canine Mast Cell Tumours.
Giuliano A; Dos Santos Horta R; Constantino-Casas F; Hoather T; Dobson J
J Comp Pathol; 2017 Jan; 156(1):14-20. PubMed ID: 27889201
[TBL] [Abstract][Full Text] [Related]
14. Impact of tumour depth, tumour location and multiple synchronous masses on the prognosis of canine cutaneous mast cell tumours.
Kiupel M; Webster JD; Miller RA; Kaneene JB
J Vet Med A Physiol Pathol Clin Med; 2005 Aug; 52(6):280-6. PubMed ID: 16050909
[TBL] [Abstract][Full Text] [Related]
15. Investigating Associations Between Proliferation Indices, C-kit, and Lymph Node Stage in Canine Mast Cell Tumors.
Krick EL; Kiupel M; Durham AC; Thaiwong T; Brown DC; Sorenmo KU
J Am Anim Hosp Assoc; 2017; 53(5):258-264. PubMed ID: 28792799
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of a two-centimeter lateral surgical margin for excision of grade I and grade II cutaneous mast cell tumors in dogs.
Fulcher RP; Ludwig LL; Bergman PJ; Newman SJ; Simpson AM; Patnaik AK
J Am Vet Med Assoc; 2006 Jan; 228(2):210-5. PubMed ID: 16426187
[TBL] [Abstract][Full Text] [Related]
17. Argyrophilic nucleolar organizing regions and Ki67 equally reflect proliferation in fine needle aspirates of normal, hyperplastic, inflamed, and neoplastic canine lymph nodes (n = 101).
Bauer NB; Zervos D; Moritz A
J Vet Intern Med; 2007; 21(5):928-35. PubMed ID: 17939545
[TBL] [Abstract][Full Text] [Related]
18. Canine subcutaneous mast cell tumour: diagnosis and prognosis.
Newman SJ; Mrkonjich L; Walker KK; Rohrbach BW
J Comp Pathol; 2007 May; 136(4):231-9. PubMed ID: 17399734
[TBL] [Abstract][Full Text] [Related]
19. Frequency of argyrophilic nucleolar organizer regions in fine-needle aspirates and biopsy specimens from mast cell tumors in dogs.
Kravis LD; Vail DM; Kisseberth WC; Ogilvie GK; Volk LM
J Am Vet Med Assoc; 1996 Oct; 209(8):1418-20. PubMed ID: 8870737
[TBL] [Abstract][Full Text] [Related]
20. Assessment of potential doubling time (Tpot), argyrophilic nucleolar organizer regions (AgNOR), and proliferating cell nuclear antigen (PCNA) as predictors of therapy response in canine non-Hodgkin's lymphoma.
Vail DM; Kisseberth WC; Obradovich JE; Moore FM; London CA; MacEwen EG; Ritter MA
Exp Hematol; 1996 Jun; 24(7):807-15. PubMed ID: 8647231
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
